| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8317458 | Clinical Biochemistry | 2014 | 6 Pages |
Abstract
The baseline level of uPAR(I-III)Â +Â uPAR(II-III) is a predictor of survival in inoperable cholangiocarcinoma patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
M. Grunnet, I.J. Christensen, U. Lassen, L.H. Jensen, M. Lydolph, I.K. Lund, T. Thurison, G. Høyer-Hansen, M. Mau-Sørensen,